Medindia
Medindia LOGIN REGISTER
Advertisement

Phase III study showed Ofev® slows the loss of pulmonary function in people living with systemic sclerosis associated ILD

Monday, May 20, 2019 General News
Advertisement
- Results of pivotal Phase III SENSCIS® trial published today in the New England Journal of Medicine (NEJM) and presented at the American Thoracic Society (ATS) International Conference in Dallas

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close